BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11605319)

  • 1. [Abdominal obesity: metabolic complications and consequences for the liver].
    De Vries AP; Bakker SJ; Gans RO
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1910-1. PubMed ID: 11605319
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abdominal obesity: metabolic complications and consequences for the liver].
    Oldenburg B; Pijl H
    Ned Tijdschr Geneeskd; 2001 Jul; 145(27):1290-4. PubMed ID: 11475019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kobashigawa K; Kinjo F; Saito A
    Hepatogastroenterology; 2003; 50(54):2005-8. PubMed ID: 14696453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis of non-alcoholic fatty liver and potential therapeutic targets].
    Crespo J; Cayón A; Pons-Romero F
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():15-23. PubMed ID: 15195530
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease: defining a common problem.
    Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morhpological and clinical findings in the liver in diabetes mellitus].
    Takác A; Langsch HG; Cossel L
    Dtsch Z Verdau Stoffwechselkr; 1967 Feb; 26(4):188-97. PubMed ID: 5595286
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated transaminases and hepatomegaly in an obese diabetic.
    Yale J Biol Med; 1983; 56(4):323-34. PubMed ID: 6670293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus, obesity, and hepatic steatosis.
    Youssef W; McCullough AJ
    Semin Gastrointest Dis; 2002 Jan; 13(1):17-30. PubMed ID: 11944630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diazoxide prevents abdominal adiposity and fatty liver in obese OLETF rats at prediabetic stage.
    Guo Z; Bu S; Yu Y; Ghatnekar G; Wang M; Chen L; Bu M; Yang L; Zhu B; Feng Z; Huang Q
    J Diabetes Complications; 2008; 22(1):46-55. PubMed ID: 18191077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver cirrhosis and diabetes mellitus.
    Muting D; Wohlgemuth D; Dorsett R
    Geriatrics; 1969 Jan; 24(1):91-9. PubMed ID: 5782543
    [No Abstract]   [Full Text] [Related]  

  • 13. [Steatohepatitis and metabolic and nutritional abnormalities].
    Deugnier Y; Lainé F
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B9-12. PubMed ID: 12843931
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of fatty liver].
    Filippini L
    Dtsch Med Wochenschr; 1969 Aug; 94(32):1619-20. PubMed ID: 5798856
    [No Abstract]   [Full Text] [Related]  

  • 15. [Differential diagnosis of diabetic and alcoholic fatty liver. Studies on 171 diabetics and 100 patients with alcohol abuse].
    Robbers H; Strohfeldt P; Krüger C
    Dtsch Med Wochenschr; 1968 Jan; 93(3):112-3. PubMed ID: 5637976
    [No Abstract]   [Full Text] [Related]  

  • 16. Relation of steatosis to cirrhosis.
    Thaler H
    Clin Gastroenterol; 1975 May; 4(2):273-80. PubMed ID: 1126047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-calorie malnutrition and the liver.
    McLaren DS; Bitar JG; Nassar VH
    Prog Liver Dis; 1972; 4():527-36. PubMed ID: 4631502
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harrison SA; Neuschwander-Tetri BA
    Clin Liver Dis; 2004 Nov; 8(4):861-79, ix. PubMed ID: 15464659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.
    Willner IR; Waters B; Patil SR; Reuben A; Morelli J; Riely CA
    Am J Gastroenterol; 2001 Oct; 96(10):2957-61. PubMed ID: 11693332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.